115 related articles for article (PubMed ID: 38383702)
21. Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma.
Zhong JT; Wang HJ; Yu J; Zhang JH; Wang SF; Yang X; Su W
Cancer Biomark; 2017; 19(2):213-220. PubMed ID: 28269757
[TBL] [Abstract][Full Text] [Related]
22. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
23. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
[TBL] [Abstract][Full Text] [Related]
24. [Effect of pretreatment serum LDH and ALP levels on the prognosis of patients with nasopharyngeal carcinoma].
Zhou JY; Chen T; Li W; Ye K; Wei ZB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(14):1069-1073. PubMed ID: 29798242
[No Abstract] [Full Text] [Related]
25. Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Tang LQ; Hu DP; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Wen SH; Peng YT; Chen WH; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mai HQ
PLoS One; 2015; 10(4):e0122965. PubMed ID: 25874450
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
Zeng X; Liu G; Pan Y; Li Y
J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Yao JJ; He XJ; Lawrence WR; Zhang WJ; Kou J; Zhang F; Zhou GQ; Wang SY; Sun Y
Cell Physiol Biochem; 2018; 48(1):285-292. PubMed ID: 30011397
[TBL] [Abstract][Full Text] [Related]
28. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
29. Nasopharyngeal carcinoma with paranasal sinus invasion: the prognostic significance and the evidence-based study basis of its T-staging category according to the AJCC staging system.
Tian L; Li YZ; Mo YX; Liu LZ; Xie CM; Liang XX; Gong X; Fan W
BMC Cancer; 2014 Nov; 14():832. PubMed ID: 25403714
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis.
Qi X; Li X; Sun X
Tumour Biol; 2016 Aug; 37(8):11099-104. PubMed ID: 26910773
[TBL] [Abstract][Full Text] [Related]
31. PI3K-PKB-mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis.
Yu JH; Chen L; Yu JY; Luo HQ; Wang L
J Cell Biochem; 2019 Jun; 120(6):10186-10194. PubMed ID: 30582216
[TBL] [Abstract][Full Text] [Related]
32. Subclassification of skull-base invasion for nasopharyngeal carcinoma using cluster, network and survival analyses: A double-center retrospective investigation.
Li HJ; Hu YY; Huang L; Zhou J; Li JJ; Xie CB; Chen MY; Sun Y; Liu LZ; Tian L
Radiother Oncol; 2019 May; 134():37-43. PubMed ID: 31005222
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy associated nasopharyngeal carcinoma: A retrospective case-control analysis of maternal survival outcomes.
Cheng YK; Zhang F; Tang LL; Chen L; Zhou GQ; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Guo Y; Ma J
Radiother Oncol; 2015 Jul; 116(1):125-30. PubMed ID: 26104977
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.
Cheng D; Kong H; Li Y
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):503-9. PubMed ID: 23749058
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma.
Mo HY; Luo DH; Qiu HZ; Liu H; Chen QY; Tang LQ; Zhong ZL; Huang PY; Zhao ZJ; Zhang CQ; Zhang Y; Mai HQ
Clin Oncol (R Coll Radiol); 2013 May; 25(5):308-17. PubMed ID: 23290342
[TBL] [Abstract][Full Text] [Related]
36. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
37. Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?
Sze H; Chan LL; Ng WT; Hung AW; Lee MC; Chang AT; Chan OS; Cheung FY; Yeung RM; Lee AW
Oral Oncol; 2014 Dec; 50(12):1188-95. PubMed ID: 25261296
[TBL] [Abstract][Full Text] [Related]
38. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.
Ai QY; King AD; Poon DMC; Mo FKF; Hui EP; Tong M; Ahuja AT; Ma BBY; Chan ATC
Oral Oncol; 2019 Jan; 88():124-130. PubMed ID: 30616782
[TBL] [Abstract][Full Text] [Related]
39. Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.
Wu L; Zhuo S; Zeng W; Liang S; Wang S; Cui C; Zhou J; Ruan G; Xu S; Wang L; Huang L; Liu L; Li H
Head Neck; 2019 Dec; 41(12):4088-4097. PubMed ID: 31518030
[TBL] [Abstract][Full Text] [Related]
40. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
